Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests

by | Mar 16, 2026 | Health

Spread the love
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most aggressive subtypes are a significant driver of that trend: uterine papillary serous carcinoma accounts for just 10% of diagnoses but nearly 40% of deaths.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments